• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

噬菌体展示技术在T细胞受体发现中的应用。

Application of phage display for T-cell receptor discovery.

作者信息

Ch'ng Angela Chiew Wen, Lam Paula, Alassiri Mohammed, Lim Theam Soon

机构信息

Institute for Research in Molecular Medicine, Universiti Sains Malaysia, 11800 Penang, Malaysia.

CellVec Private Limited, 118518, Singapore; National University of Singapore, Department of Physiology, 117597, Singapore; Duke-NUS Graduate Medical School, Cancer and Stem Cells Biology Program, 169857, Singapore.

出版信息

Biotechnol Adv. 2022 Jan-Feb;54:107870. doi: 10.1016/j.biotechadv.2021.107870. Epub 2021 Nov 18.

DOI:10.1016/j.biotechadv.2021.107870
PMID:34801662
Abstract

The immune system is tasked to keep our body unharmed and healthy. In the immune system, B- and T-lymphocytes are the two main components working together to stop and eliminate invading threats like virus particles, bacteria, fungi and parasite from attacking our healthy cells. The function of antibodies is relatively more direct in target recognition as compared to T-cell receptors (TCR) which recognizes antigenic peptides being presented on the major histocompatibility complex (MHC). Although phage display has been widely applied for antibody presentation, this is the opposite in the case of TCR. The cell surface TCR is a relatively large and complex molecule, making presentation on phage surfaces challenging. Even so, recombinant versions and modifications have been introduced to allow the growing development of TCR in phage display. In addition, the increasing application of TCR for immunotherapy has made it an important binding motif to be developed by phage display. This review will emphasize on the application of phage display for TCR discovery as well as the engineering aspect of TCR for improved characteristics.

摘要

免疫系统的任务是保护我们的身体不受伤害并保持健康。在免疫系统中,B淋巴细胞和T淋巴细胞是两个主要组成部分,它们协同工作以阻止并消除诸如病毒颗粒、细菌、真菌和寄生虫等入侵威胁对我们健康细胞的攻击。与识别呈递于主要组织相容性复合体(MHC)上的抗原肽的T细胞受体(TCR)相比,抗体在目标识别方面的功能相对更直接。尽管噬菌体展示已广泛应用于抗体呈递,但在TCR的情况中却恰恰相反。细胞表面的TCR是一个相对较大且复杂的分子,这使得在噬菌体表面进行呈递具有挑战性。即便如此,人们已经引入了重组版本和修饰方法,以促进TCR在噬菌体展示中的不断发展。此外,TCR在免疫疗法中的应用日益增加,这使其成为噬菌体展示要开发的一种重要结合基序。本综述将重点关注噬菌体展示在TCR发现中的应用以及TCR为改善特性而进行的工程改造方面。

相似文献

1
Application of phage display for T-cell receptor discovery.噬菌体展示技术在T细胞受体发现中的应用。
Biotechnol Adv. 2022 Jan-Feb;54:107870. doi: 10.1016/j.biotechadv.2021.107870. Epub 2021 Nov 18.
2
Targeting Intracellular Antigens with pMHC-Binding Antibodies: A Phage Display Approach.用 pMHC 结合抗体靶向细胞内抗原:噬菌体展示方法。
Methods Mol Biol. 2023;2702:327-345. doi: 10.1007/978-1-0716-3381-6_17.
3
Generation of TCR-Like Antibodies Using Phage Display.利用噬菌体展示技术生成类TCR抗体
Methods Mol Biol. 2015;1348:191-204. doi: 10.1007/978-1-4939-2999-3_17.
4
Functional analysis of the antigen binding site on the T cell receptor alpha chain.T细胞受体α链上抗原结合位点的功能分析
J Exp Med. 1992 Jun 1;175(6):1553-63. doi: 10.1084/jem.175.6.1553.
5
Engineering improved T cell receptors using an alanine-scan guided T cell display selection system.利用丙氨酸扫描引导的 T 细胞展示选择系统工程改造 T 细胞受体。
J Immunol Methods. 2013 Jun 28;392(1-2):1-11. doi: 10.1016/j.jim.2013.02.018. Epub 2013 Mar 13.
6
Affinity maturation of TCR-like antibodies using phage display guided by structural modeling.利用结构建模指导的噬菌体展示技术对 TCR 样抗体进行亲和力成熟。
Protein Eng Des Sel. 2022 Feb 17;35. doi: 10.1093/protein/gzac005.
7
Phage display of peptide / major histocompatibility class I complexes.肽/主要组织相容性复合体I类的噬菌体展示
Eur J Immunol. 2001 Jan;31(1):32-8. doi: 10.1002/1521-4141(200101)31:1<32::aid-immu32>3.0.co;2-6.
8
Recombinant antibodies with MHC-restricted, peptide-specific, T-cell receptor-like specificity: new tools to study antigen presentation and TCR-peptide-MHC interactions.具有MHC限制、肽特异性、T细胞受体样特异性的重组抗体:研究抗原呈递和TCR-肽-MHC相互作用的新工具。
J Mol Recognit. 2003 Sep-Oct;16(5):324-32. doi: 10.1002/jmr.640.
9
A recombinant antibody with the antigen-specific, major histocompatibility complex-restricted specificity of T cells.一种具有T细胞抗原特异性、主要组织相容性复合体限制性特异性的重组抗体。
Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):1820-4. doi: 10.1073/pnas.93.5.1820.
10
Phage display of peptide/major histocompatibility complex.
J Immunol Methods. 2000 Jul 31;241(1-2):147-58. doi: 10.1016/s0022-1759(00)00211-8.

引用本文的文献

1
Phage display enables machine learning discovery of cancer antigen-specific TCRs.噬菌体展示技术助力通过机器学习发现癌症抗原特异性T细胞受体。
Sci Adv. 2025 Jun 13;11(24):eads5589. doi: 10.1126/sciadv.ads5589. Epub 2025 Jun 11.
2
Encoding and display technologies for combinatorial libraries in drug discovery: The coming of age from biology to therapy.药物发现中组合文库的编码与展示技术:从生物学走向治疗的成熟之路。
Acta Pharm Sin B. 2024 Aug;14(8):3362-3384. doi: 10.1016/j.apsb.2024.04.006. Epub 2024 Apr 10.
3
T Cell Receptor-Directed Bispecific T Cell Engager Targeting MHC-Linked NY-ESO-1 for Tumor Immunotherapy.
用于肿瘤免疫治疗的靶向与主要组织相容性复合体(MHC)相关的NY-ESO-1的T细胞受体导向双特异性T细胞衔接器
Biomedicines. 2024 Apr 1;12(4):776. doi: 10.3390/biomedicines12040776.
4
Novel insights into TCR-T cell therapy in solid neoplasms: optimizing adoptive immunotherapy.实体瘤中TCR-T细胞疗法的新见解:优化过继性免疫疗法。
Exp Hematol Oncol. 2024 Apr 3;13(1):37. doi: 10.1186/s40164-024-00504-8.
5
The screening, identification, design and clinical application of tumor-specific neoantigens for TCR-T cells.肿瘤特异性新抗原的 TCR-T 细胞的筛选、鉴定、设计与临床应用。
Mol Cancer. 2023 Aug 30;22(1):141. doi: 10.1186/s12943-023-01844-5.
6
Phage-based peptides for pancreatic cancer diagnosis and treatment: alternative approach.用于胰腺癌诊断和治疗的基于噬菌体的肽:替代方法。
Front Microbiol. 2023 Aug 2;14:1231503. doi: 10.3389/fmicb.2023.1231503. eCollection 2023.
7
EGFR-targeted bacteriophage lambda penetrates model stromal and colorectal carcinoma tissues, is taken up into carcinoma cells, and interferes with 3-dimensional tumor formation.表皮生长因子受体靶向噬菌体 λ 穿透模型基质和结直肠癌细胞组织,被摄取进入癌细胞,并干扰三维肿瘤形成。
Front Immunol. 2022 Dec 16;13:957233. doi: 10.3389/fimmu.2022.957233. eCollection 2022.